IFNA1 and glycogen storage disease VI: Clinical studies have reported that despite developing potent cytokines and chemokines in coronavirus disease 2019 (COVID-19) patients, SARS-CoV-2 infection does not induce substantial interferon (IFN) production which indicates the lack of an IFN response (5, –, 9).